加拿大疫苗
- 主题发起人 lindamy
- 开始时间
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
Seven vaccine-makers rejected our request to produce COVID shots in Canada, Anand says
Anita Anand said she asked all seven of the firms providing vaccines to Canada to consider making them here, but our facilities were simply too smallAuthor of the article: Ryan Tumilty
Publishing date: Feb 04, 2021 • 3 days ago • 4 minute read
Procurement Minister Anita Anand announces a delay to COVID vaccine delivery via videoconference, Friday, January 15, 2021 in Ottawa. PHOTO BY ADRIAN WYLD/THE CANADIAN PRESS/FILE
OTTAWA – Procurement Minister Anita Anand said she tried to entice all of the COVID-19 vaccine manufacturers to make their product here at home, but Canada didn’t have the facilities they needed.
Speaking at the House of Commons industry committee, Anand said she asked all seven of the firms providing vaccines to Canada to consider making them here, but Canada’s facilities were simply too small.
Seven vaccine-makers rejected our request to produce COVID shots in Canada, Anand says
Liberals dropped ball on vaccine production Singh says...
“Manufacturers concluded that bio-manufacturing capacity in this country, at the time of contracting last August and September, was too limited to justify the investment of capital and expertise to start manufacturing in Canada,” she said.
None of the seven deals Canada has signed for vaccines includes significant homegrown production. The government announced a deal earlier this week with Novavax to make its vaccine in Montreal, but that is unlikely to start before December. Medicago, the one Canadian company in the vaccine portfolio, will make most of their vaccines in the U.S.
NDP Don Davies questioned Anand on whether the government had really pushed hard enough to look at making vaccines here in Canada.
“Countries like Mexico, Australia, Japan, South Korea, India, and others have done so and are producing AstraZeneca vaccines domestically,” he said. “Did Canada seek this right?”
Anand said getting an agreement with AstraZeneca wasn’t the issue, it was about having what was necessary to make vaccine here.
“The reality is that standing up new manufacturing of a vaccine requires expertise. It requires resources from the supplier and given the scarcity of resources, suppliers emphasized locations that had existing capacity and would be able to manufacture quickly.”
Several MPs asked why the government hadn’t done more to increase Canada’s domestic manufacturing capability in the last year, particularly when compared to efforts in the United Kingdom.
Simon Kennedy, a deputy minister in the industry department, said the U.K. was simply much further ahead when the pandemic began.
“The U.K. has very large contract manufacturing operators that were capable of quickly shifting to produce COVID vaccine,” he said. “The U.K. certainly pivoted, and was able to do manufacturing domestically but they were starting from a much higher base.”
Seven vaccine-makers rejected our request to produce COVID shots in Canada, Anand says
Anita Anand said she asked all seven of the firms providing vaccines to Canada to consider making them here, but our facilities were simply too small
- 注册
- 2012-09-04
- 消息
- 62,923
- 荣誉分数
- 11,326
- 声望点数
- 1,373
Seven vaccine-makers rejected our request to produce COVID shots in Canada, Anand says
Anita Anand said she asked all seven of the firms providing vaccines to Canada to consider making them here, but our facilities were simply too small
Author of the article: Ryan Tumilty
Publishing date: Feb 04, 2021 • 3 days ago • 4 minute read
Procurement Minister Anita Anand announces a delay to COVID vaccine delivery via videoconference, Friday, January 15, 2021 in Ottawa. PHOTO BY ADRIAN WYLD/THE CANADIAN PRESS/FILE
OTTAWA – Procurement Minister Anita Anand said she tried to entice all of the COVID-19 vaccine manufacturers to make their product here at home, but Canada didn’t have the facilities they needed.
Speaking at the House of Commons industry committee, Anand said she asked all seven of the firms providing vaccines to Canada to consider making them here, but Canada’s facilities were simply too small.
Seven vaccine-makers rejected our request to produce COVID shots in Canada, Anand says
Liberals dropped ball on vaccine production Singh says...
“Manufacturers concluded that bio-manufacturing capacity in this country, at the time of contracting last August and September, was too limited to justify the investment of capital and expertise to start manufacturing in Canada,” she said.
None of the seven deals Canada has signed for vaccines includes significant homegrown production. The government announced a deal earlier this week with Novavax to make its vaccine in Montreal, but that is unlikely to start before December. Medicago, the one Canadian company in the vaccine portfolio, will make most of their vaccines in the U.S.
NDP Don Davies questioned Anand on whether the government had really pushed hard enough to look at making vaccines here in Canada.
“Countries like Mexico, Australia, Japan, South Korea, India, and others have done so and are producing AstraZeneca vaccines domestically,” he said. “Did Canada seek this right?”
Anand said getting an agreement with AstraZeneca wasn’t the issue, it was about having what was necessary to make vaccine here.
“The reality is that standing up new manufacturing of a vaccine requires expertise. It requires resources from the supplier and given the scarcity of resources, suppliers emphasized locations that had existing capacity and would be able to manufacture quickly.”
Several MPs asked why the government hadn’t done more to increase Canada’s domestic manufacturing capability in the last year, particularly when compared to efforts in the United Kingdom.
Simon Kennedy, a deputy minister in the industry department, said the U.K. was simply much further ahead when the pandemic began.
“The U.K. has very large contract manufacturing operators that were capable of quickly shifting to produce COVID vaccine,” he said. “The U.K. certainly pivoted, and was able to do manufacturing domestically but they were starting from a much higher base.”
Seven vaccine-makers rejected our request to produce COVID shots in Canada, Anand says
Anita Anand said she asked all seven of the firms providing vaccines to Canada to consider making them here, but our facilities were simply too smallnationalpost.com
原来不是哪个国家都有能力生产疫苗。
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
華裔科學家邱香果和丈夫 被加拿大國家實驗室解雇
2021年02月07日 12:53
邱香果穿著全副保護裝備，在加拿大最高戒護等級的國家微生物學實驗室工作。 CBC
【星島綜合報道】加拿大國家微生物實驗室(National Microbiology Lab，簡稱NML)的華裔科學家邱香果和丈夫程克定(Keding Cheng，音譯)已證實不再受聘於加拿大公共衛生署(Public Health Agency of Canada，簡稱PHAC)。
加拿大廣播公司(CBC)報道，加拿大衛生部媒體關係主管莫里塞特（Eric Morrissette）發郵件證實證實：「自2021年1月20日起，這兩名科學家將不再受僱於加拿大公共衛生署。出於保密原因，我們不能透露其他信息，也不能發表評論。」
消息人士稱，國家微生物實驗室特殊病原體部門的成員周四在會議上被告知邱香果和丈夫不再為實驗室工作，會議中並未說明理由。兩人2019年被逐出實驗室後的這段期間處於帶薪休假狀態。
CBC早前報道，皇家騎警於2019年7月，對在本國最高戒護等級的國家微生物學實驗室工作的邱香果、程克定及邱香果部分來自中國的學生展開調查，並禁止他們進入實驗室。之後CBC再報道，該實驗室曾在2019年3月將號稱「全世界最致命病原體」伊波拉病毒(Ebola)和亨尼巴病毒(Henipah)樣本發往中國。CBC透過《資訊自由法》取得的文件顯示，把那些病毒出口到中國武漢病毒研究所的人，正是邱香果。
(位於溫尼辟的加拿大國家實驗室。 加通社資料圖片)
CBC報道稱，皇家騎警和加拿大衛生署一直否定，2019年發送到中國的病毒與當下的新冠疫情有任何關係。伊波拉病毒是一種線性病毒，亨尼巴病毒是一種副黏液病毒，沒有冠狀病毒。公共衛生署去年曾表示，這件事也不是邱香果被逐出實驗室的原因，發言人曾發聲名指：「(對邱進行的)行政調查與將病毒樣本發往中國一事無關。」
衛生部和皇家騎警對此案保持緘默的態度令一些專家感到不安。渥太華大學法學院和公共衛生學院教授阿塔蘭（Amir Attaran）說，加拿大人有權利知道更多信息。「這增加了NML員工將加拿大收集的伊波拉病毒出口到中國武漢的實驗室時採取的不當行為，甚至是違法的行為。這是一項非常可疑的交易，當涉及到一種極致命的病毒時，應該進行有力的審查。」
華裔科學家邱香果和丈夫 被加拿大國家實驗室解雇
【星島綜合報道】加拿大國家微生物實驗室(NationalMicrobiologyLab，簡稱NML)的華裔科學家邱香果和丈夫程克定(KedingCheng，音譯)已證實不再受聘於加拿大公共衛生署(PublicHealthAgencyofCanada，簡稱PHAC)。
www.singtao.ca
- 注册
- 2012-09-04
- 消息
- 62,923
- 荣誉分数
- 11,326
- 声望点数
- 1,373
華裔科學家邱香果和丈夫 被加拿大國家實驗室解雇
2021年02月07日 12:53
邱香果穿著全副保護裝備，在加拿大最高戒護等級的國家微生物學實驗室工作。 CBC
【星島綜合報道】加拿大國家微生物實驗室(National Microbiology Lab，簡稱NML)的華裔科學家邱香果和丈夫程克定(Keding Cheng，音譯)已證實不再受聘於加拿大公共衛生署(Public Health Agency of Canada，簡稱PHAC)。
加拿大廣播公司(CBC)報道，加拿大衛生部媒體關係主管莫里塞特（Eric Morrissette）發郵件證實證實：「自2021年1月20日起，這兩名科學家將不再受僱於加拿大公共衛生署。出於保密原因，我們不能透露其他信息，也不能發表評論。」
消息人士稱，國家微生物實驗室特殊病原體部門的成員周四在會議上被告知邱香果和丈夫不再為實驗室工作，會議中並未說明理由。兩人2019年被逐出實驗室後的這段期間處於帶薪休假狀態。
CBC早前報道，皇家騎警於2019年7月，對在本國最高戒護等級的國家微生物學實驗室工作的邱香果、程克定及邱香果部分來自中國的學生展開調查，並禁止他們進入實驗室。之後CBC再報道，該實驗室曾在2019年3月將號稱「全世界最致命病原體」伊波拉病毒(Ebola)和亨尼巴病毒(Henipah)樣本發往中國。CBC透過《資訊自由法》取得的文件顯示，把那些病毒出口到中國武漢病毒研究所的人，正是邱香果。
(位於溫尼辟的加拿大國家實驗室。 加通社資料圖片)
CBC報道稱，皇家騎警和加拿大衛生署一直否定，2019年發送到中國的病毒與當下的新冠疫情有任何關係。伊波拉病毒是一種線性病毒，亨尼巴病毒是一種副黏液病毒，沒有冠狀病毒。公共衛生署去年曾表示，這件事也不是邱香果被逐出實驗室的原因，發言人曾發聲名指：「(對邱進行的)行政調查與將病毒樣本發往中國一事無關。」
衛生部和皇家騎警對此案保持緘默的態度令一些專家感到不安。渥太華大學法學院和公共衛生學院教授阿塔蘭（Amir Attaran）說，加拿大人有權利知道更多信息。「這增加了NML員工將加拿大收集的伊波拉病毒出口到中國武漢的實驗室時採取的不當行為，甚至是違法的行為。這是一項非常可疑的交易，當涉及到一種極致命的病毒時，應該進行有力的審查。」
華裔科學家邱香果和丈夫 被加拿大國家實驗室解雇
【星島綜合報道】加拿大國家微生物實驗室(NationalMicrobiologyLab，簡稱NML)的華裔科學家邱香果和丈夫程克定(KedingCheng，音譯)已證實不再受聘於加拿大公共衛生署(PublicHealthAgencyofCanada，簡稱PHAC)。
是不是邱香果把加拿大生产疫苗的能力弄没了？
- 注册
- 2012-09-04
- 消息
- 62,923
- 荣誉分数
- 11,326
- 声望点数
- 1,373
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
Canada prepares for single biggest Pfizer vaccine shipment to date
By Lee Berthiaume The Canadian PressPosted February 15, 2021 7:24 am
Canada’s sluggish COVID-19 vaccination efforts are expected to get a big boost starting this week as the federal government prepares for a ramp up in the delivery of shots from Pfizer-BioNTech following a month-long lull.
The Public Health Agency of Canada has stated on its website that it expects more than 335,000 doses of the Pfizer-BioNTech vaccine to be delivered this week, though the company says the figure will be closer to 400,000.
That is because the health agency’s number is based on five doses per vial, even though the federal government recently agreed with Pfizer’s request to have six doses administered per vial.
Either way, the expected delivery will represent the single largest shipment to Canada since the start of the pandemic as Pfizer continues scaling up production after a month-long slowdown while it expanded a plant in Belgium.
Canada’s vaccination efforts slowed to a crawl during that time, taking delivery of 339,000 doses of the Pfizer-BioNTech vaccine between Jan. 18 and last week rather than the promised 1.15 million.
Pfizer is expected to deliver an even larger shipment next week, and has said it will make good on its promise to deliver a total of 4 million doses by the end of March.
The new deliveries will be welcomed by provinces and territories, which have administered the vast majority of the vaccines that they have received.
They will also likely ease some of the pressure on the federal Liberal government, which has been accused of mismanaging what amounts to the largest mass-vaccination effort in Canadian history.
1:24Trudeau confirms Pfizer vaccine delivery schedule, reiterates promise of COVID-19 vaccines for all Canadians ‘who want one’ by September
Trudeau confirms Pfizer vaccine delivery schedule, reiterates promise of COVID-19 vaccines for all Canadians ‘who want one’ by September
Prime Minister Justin Trudeau last week acknowledged the struggle with deliveries, but said things will get better in the weeks ahead, and even better than that in April, when Canada is expecting as many as one million doses a week.
“We’re approaching something we’re calling the big lift,” he said Thursday in a virtual roundtable with nurses and doctors from around Canada.
Yet the problems aren’t entirely over. Moderna — the other company whose vaccine has been approved for use in Canada so far — has confirmed its next shipment on Feb. 22 will be only 168,000 doses, two-thirds of what had been promised.
Moderna, which delivers once every three weeks, shipped 180,000 doses last week _ 80 per cent of the promised amount.
READ MORE: Despite vaccine rollout headaches, feds expect campaign to scale up soon
In addition, Pfizer’s deliveries will only meet the promised number of doses if medical professionals can adjust to extracting six doses instead of five from every vial.
Getting that sixth dose requires the use of a low dead-volume syringe, which traps less vaccine in the needle and syringe after an injection.
Canada has now ordered 72 million of those syringes, and two million were delivered last week.
Maj.-Gen. Dany Fortin, the military commander overseeing Canada’s vaccine distribution, has said those are being shipped to the provinces to be ready for Monday, though no provinces reported receiving any as of Thursday.
Provincial governments are also concerned about how easy it will be to get that sixth dose, even with the special syringes.
To date, Canada has received about 928,000 doses from Pfizer and 515,000 from Moderna.
Canada prepares for single biggest Pfizer vaccine shipment to date
After a month-long lull, Canada is expected to get a big boost starting this week with a ramp-up in the delivery of shots from Pfizer-BioNTech.
globalnews.ca
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
新冠疫苗：加拿大被指囤积疫苗 却为何接种进度落后
2021年2月13日
图像来源，REUTERS
加拿大已经预定了大量的新冠病毒疫苗，该国也成为潜在人均疫苗拥有量第一大国。不过加拿大的新挑战是，如何尽快为其民众进行成功接种。
周五，加拿大总理特鲁多承诺，大量来自辉瑞（Pfizer）和莫德纳（Moderna）的疫苗将抵达加拿大，目前该国仅批准了这两种疫苗。
但特鲁多的批评者称，疫苗的分发速度不够快，而按照特鲁多的承诺，所有想接种疫苗的加拿大人都将在9月底前成功接种疫苗。
加拿大从去年12月14日开始接种，到目前为止，该国只提供了118万多剂疫苗。根据彭博社汇编的数据，目前在全球每百人接种量排名中，加拿大排在第40位。
每100名加拿大人中只有3人接种了至少一剂，而美国和英国分别约为14人和21人。
加拿大国内已经有超过82.3万例确诊，超过2.1万人死亡。
- 疫情下的农历新年：八个理由让你享受一个人吃饭的乐趣
- 新冠疫苗接种近两月 尚未解答的四个问题
- 新冠疫苗：世卫组织批评欧盟疫苗出口管制计划
- 全球疫苗速报： 以色列有民众接种首剂疫苗后确诊 香港未放弃采购科兴疫苗
为什么加拿大落后了？
去年年底，加拿大因购买了数倍于其人口所需的疫苗而受到批评。加拿大已经与七家疫苗供应商签署了协议——除了莫德纳和辉瑞，还有像阿斯利康、强生公司这样等待批准的疫苗供应商，总计超过4亿剂，远远超过该国所需。
但两款已获授权的疫苗似乎无法优先交付。
由于担心美国前总统特朗普会发布疫苗出口禁令，加拿大决定押注在欧洲的疫苗生产商身上。不过，欧洲疫苗工厂供应紧张，再加上最近威胁实施疫苗禁令的是欧洲，而非美国，事态雪上加霜。
反观加拿大国内，则缺乏疫苗生产能力。
最近几周，莫德纳和辉瑞两种疫苗，都出现了交货延迟、减少订单或取消的情况。
一项统计显示，加拿大目前的疫苗供应量落后计划约100万剂。
截至本周，有2.43%的人口至少接种了一剂疫苗。加拿大政府数据显示，近12%的80岁以上的人和超过55%的重点医护人员已经接受了至少一剂疫苗。
特鲁多表示，供应商有望在3月底交付600万剂疫苗。
图像来源，TORONTO STAR VIA GETTY IMAGES
反应如何？
加拿大这个冬季处于严格的封锁状态，很多加拿大人对缓慢的接种进度感到沮丧。加拿大民调公司Abacus Data 2月5日表示，“疫苗交付的延迟似乎已经伤害了自由党。”
“过去几周，政府支持率、总理形象和得票比率都在下降。”
不仅如此，加拿大还决定从名为“Covax”的全球接种共享计划中获取疫苗供应，该计划旨在从较富裕的国家汇集资金，帮助他们自己和低收入国家购买疫苗。
加拿大是G7富国集团中唯一被列为现阶段Covax受益国的成员。
此举在加拿大国内遭到反对党批评，认为与穷国抢疫苗，有损加拿大国际形象，而且疫苗有限的情况下，加拿大抢到后，一些国家疫情势必加重，因此建议归还疫苗给Covax。
加拿大政府为自己的这一决定而辩解称，加入Covax原本就是为了疫苗提供渠道，不会为了想加快疫苗接种进度。
与此同时，上周五，特鲁多宣布，加拿大将提前获得一些辉瑞公司的疫苗剂量，并额外购买了400万剂莫德纳疫苗。
他表示，理解人们对最近疫苗供给中断的“焦虑”。
为了促进国内生产，加拿大上周宣布，签署协议，允许诺瓦克斯公司（Novavax）开发的一款外国新冠疫苗在国内生产。
不过，该疫苗仍处于第三阶段试验阶段，蒙特利尔的生产设施也仍在建设中。
图像来源，REUTERS
法国已注射280万剂疫苗。
法国
不少西方国家都在努力加快接种进度。相比之下，法国接种进度要优于加拿大。根据政府信息，该国已经交付了近280万剂疫苗。不过法国卫生部门近期建议，凡是以前感染过新冠病毒的人，只需接种一次疫苗，而不是通常建议的两剂。
该部门表示，新冠康复的人有一定免疫力，应在3到6个月后再接种。
法国首个提出如此建议的国家。目前，发过确诊人数已达340万人，但真实数字被认为更高，死亡人数达到8.1万人，排全球第七。
上述卫生部门提出该建议之时，世界各国政府正在争抢疫苗，急于为本国人口接种，试图让经济生活回归正轨。
æ°å ç«èï¼å æ¿å¤§è¢«æå¤ç§¯ç«è å´ä¸ºä½æ¥ç§è¿åº¦è½å - BBC News ä¸æ
å æ¿å¤§æ¯G7å¯å½éå¢ä¸å¯ä¸è¢«å为ç°é¶æ®µCovaxåçå½çæåãæ¤ä¸¾è¢«æ¹è¯ï¼ä¸ç©·å½æ¢ç«èï¼ææå æ¿å¤§å½é形象
www.bbc.com
加拿大国产疫苗今年有望交付5000万剂
@ 2021-2-17 08:59 参与评论 [ 5 ]加拿大生物科技公司Providence Therapeutics称，若自行研发的疫苗获得批准，今年可生产5,000万剂，为加拿大对抗新冠病毒大流行出力。尽管目前该疫苗仍处于早期人体临床试验阶段，但是曼尼托巴省政府已经宣布向该公司订购200万剂新冠疫苗，成为首个直接向该公司订购疫苗的省份。阿尔伯塔省长康尼也提出确保该省得到充足疫苗供应的想法。
- 注册
- 2007-01-19
- 消息
- 28,051
- 荣誉分数
- 9,528
- 声望点数
- 373
我擦，这疫苗不会瞬间变白菜了吧？加拿大国产疫苗今年有望交付5000万剂
@ 2021-2-17 08:59 参与评论 [ 5 ]
加拿大生物科技公司Providence Therapeutics称，若自行研发的疫苗获得批准，今年可生产5,000万剂，为加拿大对抗新冠病毒大流行出力。尽管目前该疫苗仍处于早期人体临床试验阶段，但是曼尼托巴省政府已经宣布向该公司订购200万剂新冠疫苗，成为首个直接向该公司订购疫苗的省份。阿尔伯塔省长康尼也提出确保该省得到充足疫苗供应的想法。
- 注册
- 2005-11-23
- 消息
- 30,365
- 荣誉分数
- 7,477
- 声望点数
- 373
加拿大自行研制的有4-5个，只有一个进入三期试验，等它的好消息。加拿大国产疫苗今年有望交付5000万剂
@ 2021-2-17 08:59 参与评论 [ 5 ]
加拿大生物科技公司Providence Therapeutics称，若自行研发的疫苗获得批准，今年可生产5,000万剂，为加拿大对抗新冠病毒大流行出力。尽管目前该疫苗仍处于早期人体临床试验阶段，但是曼尼托巴省政府已经宣布向该公司订购200万剂新冠疫苗，成为首个直接向该公司订购疫苗的省份。阿尔伯塔省长康尼也提出确保该省得到充足疫苗供应的想法。
相关推荐
